Abnova (Taiwan) Corporation (TPE:4133)
Taiwan · Delayed Price · Currency is TWD 23.70
-0.75 (-3.07%)
Mar 4, 2026, 1:35 PM CST
Abnova (Taiwan) Revenue
In the year 2025, Abnova (Taiwan) had annual revenue of 351.30M TWD, down -1.11%. Abnova (Taiwan) had revenue of 83.94M in the quarter ending December 31, 2025, a decrease of -4.66%.
Revenue
351.30M
Revenue Growth
-1.11%
P/S Ratio
4.21
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 351.30M | -3.96M | -1.11% |
| Dec 31, 2024 | 355.26M | -26.80M | -7.01% |
| Dec 31, 2023 | 382.05M | -29.70M | -7.21% |
| Dec 31, 2022 | 411.76M | -39.73M | -8.80% |
| Dec 31, 2021 | 451.49M | -4.96M | -1.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chunghwa Chemical Synthesis & Biotech | 977.79M |
| Genomics BioSci & Tech. | 607.89M |
| Meribank Biotech | 486.52M |
| GenMont Biotech Incorporation | 391.48M |
| GeneReach Biotechnology | 215.32M |
| NeoCore Technology | 190.10M |
| Lukas Biomedical | 180.32M |
| Enimmune | 42.23M |